Table 3. Effect of SR on serum lipid profile, glycosylated haemoglobin, membrane bound enzymes, C-reactive proteins and troponin levels of T2D rats.
Parameters | Group I | Group II | Group III | Group IV | Group V |
---|---|---|---|---|---|
Total cholesterol (mg/dl) | 92.33± 6.54 | 156.48 ± 13.21# | 118.67 ± 9.87* | 112.89 ± 6.21** | 105.50 ± 8.62** |
HDL cholesterol (mg/dl) | 31.21 ± 3.12 | 17.67 ± 2.11# | 25.43 ± 2.85 | 27.86 ± 2.09* | 27.98 ± 2.92* |
Triglycerides (mg/dl) | 116.75 ± 14.56 | 202.37 ± 19.22# | 156.88 ± 17.65 | 138.76 ± 14.32* | 133.56 ± 15.67* |
LDL cholesterol (mg/dl) | 37.78 ± 3.45 | 174.22 ± 9.67# | 61.47 ± 5.11** | 57.28 ± 4.98** | 50.81 ± 5.23** |
Glycosylated haemoglobin(mg/g haemoglobin) | 0.32± 0.11 | 0.63 ± 0.25# | 0.41 ± 0.16 | 0.38 ± 0.07* | 0.34 ± 0.09** |
Lactate dehydrogenase (U/l) | 187.08± 12.33 | 285.07 ± 21.15# | 218.56 ± 17.92* | 215.34 ± 18.50* | 202.58 ± 20.80* |
Creatine kinase (IU/mg of protein) | 9.42 ± 1.45 | 19.05 ± 2.04# | 13.24 ± 1.01* | 12.67 ± 1.31* | 12.33 ± 1.29** |
C-reactive protein (mg/dl) | 1.14 ± 0.48 | 3.01 ± 0.72# | 1.67 ± 0.35** | 1.41 ± 0.48** | 1.32 ± 0.29** |
Troponin I (ng/ml) | 0.045 ± 0.014 | 0.087± 0.02$ | 0.06 ± 0.017 | 0.048 ± 0.028* | 0.048 ± 0.033* |
Troponin T (ng/ml) | 0.012 ± 0.002 | 0.027 ± 0.003# | 0.02 ± 0.007* | 0.017 ± 0.0008** | 0.015 ± 0.003** |
Data were expressed as mean ± SD (n = 6).
$p< 0.05 compared with Group I
#p< 0.01 compared with Group I
*p< 0.05 compared with Group II
**p< 0.01 compared with Group II.
Group I: Normal control; Group II: T2D control, Group III: T2D rats treated with SR (50 mg/kg, p.o.); Group IV: T2D rats treated with SR (100 mg/kg, p.o.); Group V: T2D rats treated with glibenclamide (1 mg/kg, p.o.).